51 Labs

51 Labs is a specialized venture studio focused on the longevity and healthspan sector, launched by the venture capital firm LongeVC. The studio operates as an incubator that identifies high-potential longevity technologies and provides them with the necessary infrastructure, funding, and strategic guidance to transition from academic concepts to viable biotech startups. By leveraging a network of industry experts and scientific advisors, 51 Labs aims to accelerate the development of therapeutics and diagnostics targeting age-related diseases. The company's primary mission is to bridge the gap between early-stage research and commercial clinical development within the rapidly growing field of geroscience.